Tag: Acrivon


Acrivon cuts IPO price to raise $99M for plan to revive old Lilly cancer drug

November 15, 2022

Via: Biopharma Dive

Like a number of the other biotech startups to reach Wall Street this year, Acrivon is primarily focused on a single drug and getting it to market. Its lead drug is prexasertib, a small molecule targeting a pair of enzymes […]